Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation
Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II...
Gespeichert in:
Veröffentlicht in: | Transplantation direct 2016-01, Vol.2 (1), p.e54-e54 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e54 |
---|---|
container_issue | 1 |
container_start_page | e54 |
container_title | Transplantation direct |
container_volume | 2 |
creator | Balamurugan, Appakalai N. Green, Michael L. Breite, Andrew G. Loganathan, Gopalakrishnan Wilhelm, Joshua J. Tweed, Benjamin Vargova, Lenka Lockridge, Amber Kuriti, Manikya Hughes, Michael G. Williams, Stuart K. Hering, Bernhard J. Dwulet, Francis E. McCarthy, Robert C. |
description | Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation.
We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42).
Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (>5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas.
A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets. |
doi_str_mv | 10.1097/TXD.0000000000000563 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4946501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1810357266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</originalsourceid><addsrcrecordid>eNpdkUtv1DAUhSMEolXpP0DISzYpfiVONkjVMLSRKlWig8TOcpzrGYNjF9tpNWz7x8n0xVAv7Gv5nO_66hTFe4JPCG7Fp9WPLyd4f1U1e1UcUiZY2QhGXu_VB8VxSj9nDeF1zSl7WxxQUWFMuTgs7roBfLZma_0aLY0Bne0NoKX_sx0Bne5uNm_RSsU15IRMiOgb6DD21iuf0cKplFCHlB-e6g4tgnNqDV4luDdcTVpDSmZy6HwalUddcpDnPTiVbfDvijdGuQTHj-dR8f3rcrU4Ly8uz7rF6UWpK9LyUlRDrzSmVHCqhwY3VPeE9LofhpoL0bfKDNhwjDntRWsYByUE8KECykivODsqPj9wr6d-hEHPg0fl5HW0o4pbGZSV_794u5HrcCN5y-sKkxnw8REQw-8JUpajTRrmaT2EKUnSEMwqQet6lvIHqY4hpQjmuQ3BchehnCOULyOcbR_2v_hsegrsH_c2uAwx_XLTLUS5AeXyRmLS8IrSpqSY1JjM0HJH5uwvqA6o2g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1810357266</pqid></control><display><type>article</type><title>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</title><source>DOAJ Directory of Open Access Journals</source><source>Journals@Ovid Complete</source><source>Wolters Kluwer Open Health</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Balamurugan, Appakalai N. ; Green, Michael L. ; Breite, Andrew G. ; Loganathan, Gopalakrishnan ; Wilhelm, Joshua J. ; Tweed, Benjamin ; Vargova, Lenka ; Lockridge, Amber ; Kuriti, Manikya ; Hughes, Michael G. ; Williams, Stuart K. ; Hering, Bernhard J. ; Dwulet, Francis E. ; McCarthy, Robert C.</creator><creatorcontrib>Balamurugan, Appakalai N. ; Green, Michael L. ; Breite, Andrew G. ; Loganathan, Gopalakrishnan ; Wilhelm, Joshua J. ; Tweed, Benjamin ; Vargova, Lenka ; Lockridge, Amber ; Kuriti, Manikya ; Hughes, Michael G. ; Williams, Stuart K. ; Hering, Bernhard J. ; Dwulet, Francis E. ; McCarthy, Robert C.</creatorcontrib><description>Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation.
We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42).
Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (>5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas.
A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets.</description><identifier>ISSN: 2373-8731</identifier><identifier>EISSN: 2373-8731</identifier><identifier>DOI: 10.1097/TXD.0000000000000563</identifier><identifier>PMID: 27500247</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc</publisher><subject>Pancreas and Islet Transplantation</subject><ispartof>Transplantation direct, 2016-01, Vol.2 (1), p.e54-e54</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2015 The Authors. Transplantation Direct. Published by Wolters Kluwer Health, Inc. 2015 The Authors. Transplantation Direct. Published by Wolters Kluwer Health, Inc</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</citedby><cites>FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946501/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946501/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27500247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balamurugan, Appakalai N.</creatorcontrib><creatorcontrib>Green, Michael L.</creatorcontrib><creatorcontrib>Breite, Andrew G.</creatorcontrib><creatorcontrib>Loganathan, Gopalakrishnan</creatorcontrib><creatorcontrib>Wilhelm, Joshua J.</creatorcontrib><creatorcontrib>Tweed, Benjamin</creatorcontrib><creatorcontrib>Vargova, Lenka</creatorcontrib><creatorcontrib>Lockridge, Amber</creatorcontrib><creatorcontrib>Kuriti, Manikya</creatorcontrib><creatorcontrib>Hughes, Michael G.</creatorcontrib><creatorcontrib>Williams, Stuart K.</creatorcontrib><creatorcontrib>Hering, Bernhard J.</creatorcontrib><creatorcontrib>Dwulet, Francis E.</creatorcontrib><creatorcontrib>McCarthy, Robert C.</creatorcontrib><title>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</title><title>Transplantation direct</title><addtitle>Transplant Direct</addtitle><description>Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation.
We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42).
Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (>5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas.
A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets.</description><subject>Pancreas and Islet Transplantation</subject><issn>2373-8731</issn><issn>2373-8731</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpdkUtv1DAUhSMEolXpP0DISzYpfiVONkjVMLSRKlWig8TOcpzrGYNjF9tpNWz7x8n0xVAv7Gv5nO_66hTFe4JPCG7Fp9WPLyd4f1U1e1UcUiZY2QhGXu_VB8VxSj9nDeF1zSl7WxxQUWFMuTgs7roBfLZma_0aLY0Bne0NoKX_sx0Bne5uNm_RSsU15IRMiOgb6DD21iuf0cKplFCHlB-e6g4tgnNqDV4luDdcTVpDSmZy6HwalUddcpDnPTiVbfDvijdGuQTHj-dR8f3rcrU4Ly8uz7rF6UWpK9LyUlRDrzSmVHCqhwY3VPeE9LofhpoL0bfKDNhwjDntRWsYByUE8KECykivODsqPj9wr6d-hEHPg0fl5HW0o4pbGZSV_794u5HrcCN5y-sKkxnw8REQw-8JUpajTRrmaT2EKUnSEMwqQet6lvIHqY4hpQjmuQ3BchehnCOULyOcbR_2v_hsegrsH_c2uAwx_XLTLUS5AeXyRmLS8IrSpqSY1JjM0HJH5uwvqA6o2g</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Balamurugan, Appakalai N.</creator><creator>Green, Michael L.</creator><creator>Breite, Andrew G.</creator><creator>Loganathan, Gopalakrishnan</creator><creator>Wilhelm, Joshua J.</creator><creator>Tweed, Benjamin</creator><creator>Vargova, Lenka</creator><creator>Lockridge, Amber</creator><creator>Kuriti, Manikya</creator><creator>Hughes, Michael G.</creator><creator>Williams, Stuart K.</creator><creator>Hering, Bernhard J.</creator><creator>Dwulet, Francis E.</creator><creator>McCarthy, Robert C.</creator><general>The Authors. Published by Wolters Kluwer Health, Inc</general><general>Lippincott Williams & Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</title><author>Balamurugan, Appakalai N. ; Green, Michael L. ; Breite, Andrew G. ; Loganathan, Gopalakrishnan ; Wilhelm, Joshua J. ; Tweed, Benjamin ; Vargova, Lenka ; Lockridge, Amber ; Kuriti, Manikya ; Hughes, Michael G. ; Williams, Stuart K. ; Hering, Bernhard J. ; Dwulet, Francis E. ; McCarthy, Robert C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Pancreas and Islet Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balamurugan, Appakalai N.</creatorcontrib><creatorcontrib>Green, Michael L.</creatorcontrib><creatorcontrib>Breite, Andrew G.</creatorcontrib><creatorcontrib>Loganathan, Gopalakrishnan</creatorcontrib><creatorcontrib>Wilhelm, Joshua J.</creatorcontrib><creatorcontrib>Tweed, Benjamin</creatorcontrib><creatorcontrib>Vargova, Lenka</creatorcontrib><creatorcontrib>Lockridge, Amber</creatorcontrib><creatorcontrib>Kuriti, Manikya</creatorcontrib><creatorcontrib>Hughes, Michael G.</creatorcontrib><creatorcontrib>Williams, Stuart K.</creatorcontrib><creatorcontrib>Hering, Bernhard J.</creatorcontrib><creatorcontrib>Dwulet, Francis E.</creatorcontrib><creatorcontrib>McCarthy, Robert C.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transplantation direct</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balamurugan, Appakalai N.</au><au>Green, Michael L.</au><au>Breite, Andrew G.</au><au>Loganathan, Gopalakrishnan</au><au>Wilhelm, Joshua J.</au><au>Tweed, Benjamin</au><au>Vargova, Lenka</au><au>Lockridge, Amber</au><au>Kuriti, Manikya</au><au>Hughes, Michael G.</au><au>Williams, Stuart K.</au><au>Hering, Bernhard J.</au><au>Dwulet, Francis E.</au><au>McCarthy, Robert C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</atitle><jtitle>Transplantation direct</jtitle><addtitle>Transplant Direct</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2</volume><issue>1</issue><spage>e54</spage><epage>e54</epage><pages>e54-e54</pages><issn>2373-8731</issn><eissn>2373-8731</eissn><abstract>Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation.
We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42).
Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (>5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas.
A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc</pub><pmid>27500247</pmid><doi>10.1097/TXD.0000000000000563</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2373-8731 |
ispartof | Transplantation direct, 2016-01, Vol.2 (1), p.e54-e54 |
issn | 2373-8731 2373-8731 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4946501 |
source | DOAJ Directory of Open Access Journals; Journals@Ovid Complete; Wolters Kluwer Open Health; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Pancreas and Islet Transplantation |
title | Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A50%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identifying%20Effective%20Enzyme%20Activity%20Targets%20for%20Recombinant%20Class%20I%20and%20Class%20II%20Collagenase%20for%20Successful%20Human%20Islet%20Isolation&rft.jtitle=Transplantation%20direct&rft.au=Balamurugan,%20Appakalai%20N.&rft.date=2016-01-01&rft.volume=2&rft.issue=1&rft.spage=e54&rft.epage=e54&rft.pages=e54-e54&rft.issn=2373-8731&rft.eissn=2373-8731&rft_id=info:doi/10.1097/TXD.0000000000000563&rft_dat=%3Cproquest_pubme%3E1810357266%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1810357266&rft_id=info:pmid/27500247&rfr_iscdi=true |